Track Trupanion, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Trupanion, Inc. TRUP · Stock Open Trupanion, Inc. in new tab

33.68 USD
P/E
57.83
EPS
0.53
P/B
3.28
ROE
6.07
Beta
1.30
Target Price
33.25 USD
Trupanion, Inc. logo

Trupanion, Inc.

🧾 Earnings Recap – Q2 2026

Trupanion’s shares jumped 14.2% following results that demonstrated clear acceleration in pet acquisition and improving unit economics, boosting investor confidence in growth and profitability prospects.

  • Net subscription pets added in the quarter increased 39% year-over-year to approximately 18,800, driven by initiatives enhancing the enrollment experience and pet acquisition investments.
  • Subscription adjusted operating income grew 24% year-over-year, supporting the company’s target of $180 million total adjusted operating income in 2026.
  • Average monthly revenue per pet rose 9% year-over-year to $87.44, reflecting pricing discipline and product enhancements including expanded deductible and coinsurance options.
  • Retention remained strong and improved marginally to 98.37% over the trailing 12 months.
  • The lifetime value of new enrolled pets increased 25%, indicating better alignment of acquisition costs with long-term economics despite a slight decline in value proposition (cost of paying vet invoices) to 70.2%.
📅
Loading chart...
Key Metrics
Earnings dateNov. 5, 2026
P/E57.83
EPS0.53
Book Value9.34
Price to Book3.28
Debt/Equity26.10
% Insiders15.686%
Growth
Revenue Growth0.11%
Earnings Growth-0.29%
Estimates
Forward P/E7.19
Forward EPS4.26
Target Mean Price33.25

DCF valuation

Model fair value for Trupanion, Inc. (TRUP)
Result
Sign in to run the valuation for TRUP.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
4 analysts · consensus Buy · mean target 33.25 USD (low 29.00, high 42.00) · as of 3 Nov 2026
Low 29.00
Mean 33.25
High 42.00
Price 33.68
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Trupanion, Inc. Logo Trupanion, Inc. Analysis (TRUP)

United States Financials Official Website Stock

Is Trupanion, Inc. a good investment? Trupanion, Inc. (TRUP) is currently trading at 33.68 USD. Market analysts have a consensus price target of 33.25 USD. This suggests the asset is currently trading above analyst expectations.

In terms of valuation, the stock trades at a P/E ratio of 57.83. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Trupanion, Inc. is expected to release its next earnings report on Nov. 5, 2026. The market consensus estimate for Forward EPS is 4.26.

Investor FAQ

Does Trupanion, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Trupanion, Inc.?

Trupanion, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of 0.53.

Company Profile

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, and Continental Europe. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. and changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.

Exchange Ticker
FRA (Germany) TPW.F
LSE (United Kingdom) 0LH0.L
NGM (Sweden) TRUP
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion